IL152429A0 - Transgenically produced decorin - Google Patents

Transgenically produced decorin

Info

Publication number
IL152429A0
IL152429A0 IL15242901A IL15242901A IL152429A0 IL 152429 A0 IL152429 A0 IL 152429A0 IL 15242901 A IL15242901 A IL 15242901A IL 15242901 A IL15242901 A IL 15242901A IL 152429 A0 IL152429 A0 IL 152429A0
Authority
IL
Israel
Prior art keywords
transgenically produced
produced decorin
decorin
transgenically
produced
Prior art date
Application number
IL15242901A
Other languages
English (en)
Original Assignee
Gtc Bioterapeutics Inc
Integra Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtc Bioterapeutics Inc, Integra Lifesciences Corp filed Critical Gtc Bioterapeutics Inc
Publication of IL152429A0 publication Critical patent/IL152429A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/102—Caprine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15242901A 2000-05-05 2001-05-04 Transgenically produced decorin IL152429A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20193200P 2000-05-05 2000-05-05
PCT/US2001/014408 WO2001085192A1 (en) 2000-05-05 2001-05-04 Transgenically produced decorin

Publications (1)

Publication Number Publication Date
IL152429A0 true IL152429A0 (en) 2003-05-29

Family

ID=22747872

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15242901A IL152429A0 (en) 2000-05-05 2001-05-04 Transgenically produced decorin

Country Status (14)

Country Link
US (2) US20040205832A1 (de)
EP (1) EP1282433A4 (de)
JP (1) JP2003532681A (de)
KR (1) KR20030060772A (de)
CN (1) CN1431911A (de)
AU (2) AU5946501A (de)
BR (1) BR0110577A (de)
CA (1) CA2408124A1 (de)
HU (1) HUP0302396A2 (de)
IL (1) IL152429A0 (de)
MX (1) MXPA02010907A (de)
NO (1) NO20025289L (de)
NZ (1) NZ522971A (de)
WO (1) WO2001085192A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000007I2 (de) 1986-04-09 2010-12-30 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
JP2005519914A (ja) * 2002-01-23 2005-07-07 インスティチュート オブ ニュートラシューティカル リサーチ ピーティーワイ リミテッド 結合組織の治療、防御および回復のためのニュートラシューティカルズ（ｎｕｔｒａｃｅｕｔｉｃａｌｓ）
WO2006057466A1 (en) 2004-11-23 2006-06-01 Korea Research Institute Of Bioscience And Biotechnology Beta-casein gene targeting vector using homologous recombination
KR100754114B1 (ko) * 2004-11-24 2007-08-30 한국생명공학연구원 상동 재조합을 이용하는 소 베타-카제인 유전자 타겟팅벡터
KR100747646B1 (ko) 2005-02-25 2007-08-08 연세대학교 산학협력단 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물
EP3834851A1 (de) 2010-12-30 2021-06-16 Laboratoire Français du Fractionnement et des Biotechnologies Glykole als pathogeninaktivierungsstoffe
DK2686335T3 (en) * 2011-03-14 2018-07-30 Catalant Pharma Solutions Llc DECORINE COMPOSITIONS AND APPLICATION THEREOF
EP3594231A1 (de) 2013-02-13 2020-01-15 Laboratoire Français du Fractionnement et des Biotechnologies In hohem masse galactosylierte anti-tnf-alpha-antikörper und verwendungen davon
CN105263319A (zh) 2013-02-13 2016-01-20 法国化学与生物科技实验室 具有经修饰的糖基化的蛋白及其生产方法
WO2014176198A1 (en) 2013-04-22 2014-10-30 Catalent Pharma Solutions, Llc Veterinary decorin compositions and use thereof
US10611826B2 (en) 2013-07-05 2020-04-07 Laboratoire Français Du Fractionnement Et Des Biotechnologies Affinity chromatography matrix
JP7419070B2 (ja) * 2017-04-20 2024-01-22 ザ・ユニバーシティ・オブ・シカゴ 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物
CN115992178A (zh) * 2022-08-08 2023-04-21 首都医科大学附属北京天坛医院 核心蛋白聚糖转基因小鼠的制备方法及应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
US4407956A (en) * 1981-03-13 1983-10-04 The Regents Of The University Of California Cloned cauliflower mosaic virus DNA as a plant vehicle
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
US5573933A (en) * 1987-04-14 1996-11-12 Luminis Pty, Ltd. Transgenic pigs
AU633011B2 (en) * 1988-06-28 1993-01-21 La Jolla Cancer Research Foundation Suppression of cell proliferation by decorin
US5654270A (en) * 1988-06-28 1997-08-05 La Jolla Cancer Research Foundation Use of fibromodulin to prevent or reduce dermal scarring
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US4897465A (en) * 1988-10-12 1990-01-30 Abbott Laboratories Enrichment and concentration of proteins by ultrafiltration
US5198346A (en) * 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5231020A (en) * 1989-03-30 1993-07-27 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5225341A (en) * 1990-07-19 1993-07-06 The Regents Of The University Of California Biologically safe plant transformation system using a ds transposon
US5965788A (en) * 1992-06-12 1999-10-12 Institut National De La Recherche Agronomique Transgenic non-human mammal comprising a rabbit WAP promoter
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5510328A (en) * 1994-04-28 1996-04-23 La Jolla Cancer Research Foundation Compositions that inhibit wound contraction and methods of using same
US5843705A (en) * 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
EP0937137A4 (de) * 1996-06-06 2002-10-23 Univ Washington Perlecan exprimierende transgene tiere und verfahren zur identifikation von verbindungen zur behandlung der amyloidose
WO1999054491A1 (en) * 1998-04-20 1999-10-28 Children's Hospital Medical Center Use of murine myosin heavy chain promoters for gene therapy and production of transgenics

Also Published As

Publication number Publication date
CA2408124A1 (en) 2001-11-15
US20050160483A1 (en) 2005-07-21
NO20025289L (no) 2002-12-19
JP2003532681A (ja) 2003-11-05
HUP0302396A2 (hu) 2003-10-28
US20040205832A1 (en) 2004-10-14
CN1431911A (zh) 2003-07-23
WO2001085192A1 (en) 2001-11-15
NO20025289D0 (no) 2002-11-04
NZ522971A (en) 2005-02-25
EP1282433A1 (de) 2003-02-12
BR0110577A (pt) 2003-12-30
AU2001259465B2 (en) 2006-12-07
EP1282433A4 (de) 2004-08-11
AU5946501A (en) 2001-11-20
MXPA02010907A (es) 2004-09-06
KR20030060772A (ko) 2003-07-16

Similar Documents

Publication Publication Date Title
AU7121101A (en) Case
TW539393U (en) 089204149
DE60115644D1 (en) Thiazinoxazolidinon
GB0002847D0 (en) Ampligier arrangement
HK1051196A1 (en) Linezolid-crystal form ii
AU5946501A (en) Transgenically produced decorin
GB0001301D0 (en) Appearance modelling
GB0104243D0 (en) Floodstoppers 2
GB0007203D0 (en) Supertrowel 2000
CA89509S (en) Puppet
AU142328S (en) Case
AU142321S (en) Case
AU142327S (en) Case
AU148807S (en) Case
AU142329S (en) Case
GB0019112D0 (en) Biopower 2
PL111719U1 (en) Shape
PL111436U1 (en) Triple-u shape
PL111716U1 (en) Shape
PL110577U1 (en) Shape
PL111721U1 (en) Shape
PL111722U1 (en) Shape
PL111724U1 (en) Shape
PL111774U1 (en) Shape
PL111775U1 (en) Shape